{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:40:32Z","timestamp":1792017632185,"version":"4.4.0"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1038\/ajg.2010.349","type":"journal-article","created":{"date-parts":[[2010,8,31]],"date-time":"2010-08-31T11:26:02Z","timestamp":1283253962000},"page":"2646-2655","source":"Crossref","is-referenced-by-count":44,"title":["Non-Steroidal Anti-Inflammatory Drug Use and Colorectal Polyps in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial"],"prefix":"10.14309","volume":"105","author":[{"given":"Christine Cole","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E","family":"Schoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J","family":"Gunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-24-20210210","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-146-5-200703060-00009","article-title":"et al. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. preventive services task force.","volume":"146","author":"Dube","year":"2007","journal-title":"Ann Intern Med"},{"key":"R3-24-20210210","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1053\/j.gastro.2008.02.012","article-title":"Chemoprevention of colorectal neoplasia: the potential for personalized medicine.","volume":"134","author":"Arber","year":"2008","journal-title":"Gastroenterology"},{"key":"R4-24-20210210","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7326\/0003-4819-146-5-200703060-00010","article-title":"Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.","volume":"146","author":"Rostom","year":"2007","journal-title":"Ann Intern Med"},{"key":"R5-24-20210210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00004836-200202000-00003","article-title":"The role of eicosanoids, cyclooxygenases, and nonsteroidal anti-inflammatory drugs in colorectal tumorigenesis and chemoprevention.","volume":"34","author":"Peleg","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"R6-24-20210210","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","article-title":"Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.","volume":"94","author":"Thun","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R7-24-20210210","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev.med.51.1.511","article-title":"Nonsteroidal anti-inflammatory drugs and cancer prevention.","volume":"51","author":"Baron","year":"2000","journal-title":"Annu Rev Med"},{"key":"R8-24-20210210","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1470-2045(02)00680-0","article-title":"Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention.","volume":"3","author":"Chan","year":"2002","journal-title":"Lancet Oncol"},{"key":"R9-24-20210210","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1345\/aph.1C489","article-title":"Use of NSAIDs for the chemoprevention of colorectal cancer.","volume":"37","author":"Herendeen","year":"2003","journal-title":"Ann Pharmacother"},{"key":"R11-24-20210210","first-page":"559","article-title":"Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review).","volume":"13","author":"Harris","year":"2005","journal-title":"Oncol Rep"},{"key":"R12-24-20210210","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","article-title":"A randomized trial of aspirin to prevent colorectal adenomas.","volume":"348","author":"Baron","year":"2003","journal-title":"N Engl J Med"},{"key":"R13-24-20210210","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa021633","article-title":"A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.","volume":"348","author":"Sandler","year":"2003","journal-title":"N Engl J Med"},{"key":"R14-24-20210210","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.294.8.914","article-title":"Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.","volume":"294","author":"Chan","year":"2005","journal-title":"JAMA"},{"key":"R15-24-20210210","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(07)60747-8","article-title":"Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.","volume":"369","author":"Flossmann","year":"2007","journal-title":"Lancet"},{"key":"R16-24-20210210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.gastro.2007.10.014","article-title":"Aspirin and folic acid for the prevention of recurrent colorectal adenomas.","volume":"134","author":"Logan","year":"2008","journal-title":"Gastroenterology"},{"key":"R17-24-20210210","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1023\/A:1024990617158","article-title":"Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States).","volume":"14","author":"Tangrea","year":"2003","journal-title":"Cancer Causes Control"},{"key":"R18-24-20210210","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10350-003-0111-9","article-title":"Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review.","volume":"47","author":"Asano","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"R19-24-20210210","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00001648-200007000-00003","article-title":"Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study.","volume":"11","author":"Garcia Rodriguez","year":"2000","journal-title":"Epidemiology"},{"key":"R20-24-20210210","first-page":"837","article-title":"A pleiotropic antiatherogenic action of ibuprofen.","volume":"7","author":"Zapolska-Downar","year":"2001","journal-title":"Med Sci Monit"},{"key":"R21-24-20210210","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/jnci\/90.20.1529","article-title":"Cyclooxygenase-2 inhibitors in tumorigenesis (part I).","volume":"90","author":"Taketo","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R22-24-20210210","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","article-title":"The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.","volume":"342","author":"Steinbach","year":"2000","journal-title":"N Engl J Med"},{"key":"R23-24-20210210","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/sj.bjc.6602455","article-title":"Aspirin-induced nuclear translocation of NFkappaB and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiency.","volume":"92","author":"Din","year":"2005","journal-title":"Br J Cancer"},{"key":"R24-24-20210210","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrc1801","article-title":"Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics.","volume":"6","author":"Ulrich","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"R25-24-20210210","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/ije\/dym194","article-title":"Commentary: aspirin and cancer prevention.","volume":"36","author":"Kune","year":"2007","journal-title":"Int J Epidemiol"},{"key":"R26-24-20210210","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1158\/1055-9965.EPI-08-0167","article-title":"Cyclooxygenase-2 inhibitors in colorectal cancer prevention: point.","volume":"17","author":"Arber","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R27-24-20210210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1542-3565(03)00284-2","article-title":"Hyperplastic polyps and colorectal cancer: is there a link?","volume":"2","author":"Jass","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R28-24-20210210","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/jnci\/dji175","article-title":"Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.","volume":"97","author":"Weissfeld","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R29-24-20210210","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(02)11032-4","article-title":"Evidence from randomised trials on the long-term effects of hormone replacement therapy.","volume":"360","author":"Beral","year":"2002","journal-title":"Lancet"},{"key":"R30-24-20210210","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10552-005-4500-3","article-title":"Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States).","volume":"16","author":"Purdue","year":"2005","journal-title":"Cancer Causes Control"},{"key":"R31-24-20210210","first-page":"227","article-title":"Recent use of hormone replacement therapy and the prevalence of colorectal adenomas.","volume":"7","author":"Chen","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R32-24-20210210","first-page":"622","article-title":"Risk factors for advanced colorectal adenomas: a pooled analysis.","volume":"11","author":"Terry","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R33-24-20210210","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199509073331001","article-title":"Aspirin and the risk of colorectal cancer in women.","volume":"333","author":"Giovannucci","year":"1995","journal-title":"N Engl J Med"},{"key":"R34-24-20210210","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJMp030005","article-title":"Aspirin and the prevention of colorectal cancer.","volume":"348","author":"Imperiale","year":"2003","journal-title":"N Engl J Med"},{"key":"R35-24-20210210","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.curtheres.2004.06.001","article-title":"Chemopreventive effect of nonsteroidal anti-inflammatory drugs on the development of a new colorectal polyp or adenoma in a high-risk population: a meta-analysis.","volume":"65","author":"Kanik","year":"2004","journal-title":"Curr Therap Res-Clin Exp"},{"key":"R36-24-20210210","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/sj.bjc.6603442","article-title":"Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden.","volume":"95","author":"Larsson","year":"2006","journal-title":"Br J Cancer"},{"key":"R37-24-20210210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/sj.bjc.6690651","article-title":"Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing.","volume":"81","author":"Collet","year":"1999","journal-title":"Br J Cancer"},{"key":"R38-24-20210210","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.gastro.2007.09.035","article-title":"Aspirin dose and duration of use and risk of colorectal cancer in men.","volume":"134","author":"Chan","year":"2008","journal-title":"Gastroenterology"},{"key":"R39-24-20210210","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1001\/jama.290.22.2959","article-title":"Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals.","volume":"290","author":"Lieberman","year":"2003","journal-title":"JAMA"},{"key":"R40-24-20210210","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0016-5085(03)00887-4","article-title":"Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial.","volume":"125","author":"Benamouzig","year":"2003","journal-title":"Gastroenterology"},{"key":"R41-24-20210210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1980.tb04760.x","article-title":"Acetylation of prostaglandin endoperoxide synthetase with acetylsalicylic acid.","volume":"109","author":"Van Der Ouderaa","year":"1980","journal-title":"Eur J Biochem"},{"key":"R42-24-20210210","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199112053252301","article-title":"Aspirin use and reduced risk of fatal colon cancer.","volume":"325","author":"Thun","year":"1991","journal-title":"N Engl J Med"},{"key":"R43-24-20210210","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/pgmj.2003.008227","article-title":"Non-steroidal anti-inflammatory drugs and colorectal cancer prevention.","volume":"81","author":"Sangha","year":"2005","journal-title":"Postgrad Med J"},{"key":"R44-24-20210210","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.amjmed.2005.11.011","article-title":"Colorectal cancer after start of nonsteroidal anti-inflammatory drug use.","volume":"119","author":"Sturmer","year":"2006","journal-title":"Am J Med"},{"key":"R45-24-20210210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.294.1.47","article-title":"Low-dose aspirin in the primary prevention of cancer: the Womens Health Study: a randomized controlled trial.","volume":"294","author":"Cook","year":"2005","journal-title":"JAMA"},{"key":"R46-24-20210210","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"R47-24-20210210","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1056\/NEJMe058051","article-title":"The puzzle of aspirin and sex.","volume":"352","author":"Levin","year":"2005","journal-title":"N Engl J Med"},{"key":"R48-24-20210210","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1126\/science.308.5728.1572","article-title":"Gender in the pharmacy: does it matter?","volume":"308","author":"Kaiser","year":"2005","journal-title":"Science"},{"key":"R49-24-20210210","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-140-3-200402030-00006","article-title":"A prospective study of aspirin use and the risk for colorectal adenoma.","volume":"140","author":"Chan","year":"2004","journal-title":"Ann Intern Med"},{"key":"R50-24-20210210","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-121-4-199408150-00001","article-title":"Aspirin use and the risk for colorectal cancer and adenoma in male health professionals.","volume":"121","author":"Giovannucci","year":"1994","journal-title":"Ann Intern Med"},{"key":"R51-24-20210210","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s10552-006-0075-x","article-title":"Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States).","volume":"17","author":"Kim","year":"2006","journal-title":"Cancer Causes Control"},{"key":"R52-24-20210210","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2165\/00002512-200623060-00006","article-title":"Do older adults using NSAIDs have a reduced risk of colorectal cancer?","volume":"23","author":"Hoffmeister","year":"2006","journal-title":"Drugs Aging"},{"key":"R53-24-20210210","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1158\/1055-9965.EPI-07-0710","article-title":"Cyclooxygenase-2 inhibitors in colorectal cancer prevention: counterpoint.","volume":"17","author":"Jankowski","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R54-24-20210210","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJMoa061355","article-title":"Celecoxib for the prevention of sporadic colorectal adenomas.","volume":"355","author":"Bertagnolli","year":"2006","journal-title":"N Engl J Med"},{"key":"R55-24-20210210","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/aje\/kwi248","article-title":"Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites.","volume":"162","author":"Sansbury","year":"2005","journal-title":"Am J Epidemiol"},{"key":"R56-24-20210210","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/aje\/kwk075","article-title":"Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial.","volume":"165","author":"Pinsky","year":"2007","journal-title":"Am J Epidemiol"},{"key":"R57-24-20210210","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1158\/1055-9965.EPI-06-0528","article-title":"Recruitment in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial: the First Phase of Recruitment at Henry Ford Health System.","volume":"17","author":"Lamerato","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R58-24-20210210","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1158\/1055-9965.EPI-04-0510","article-title":"PTGS2 (COX-2) 765G C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.","volume":"14","author":"Ulrich","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R59-24-20210210","first-page":"3566","article-title":"CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk.","volume":"61","author":"Bigler","year":"2001","journal-title":"Cancer Res"},{"key":"R60-24-20210210","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/jnci\/dji066","article-title":"Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma.","volume":"97","author":"Chan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R61-24-20210210","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.tpj.6500487","article-title":"A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia.","volume":"8","author":"Cross","year":"2008","journal-title":"Pharmacogenomics J"},{"key":"R62-24-20210210","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1158\/1055-9965.EPI-04-0878","article-title":"The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland.","volume":"14","author":"Macarthur","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R63-24-20210210","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7326\/0003-4819-146-5-200703060-00008","article-title":"S. Preventive Services Task Force. Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement.","volume":"146","year":"2007","journal-title":"Ann Intern Med"},{"key":"R64-24-20210210","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1053\/j.gastro.2007.11.024","article-title":"Chemoprevention for colorectal cancer: some progress but a long way to go.","volume":"134","author":"Lance","year":"2008","journal-title":"Gastroenterology"},{"key":"R65-24-20210210","doi-asserted-by":"crossref","first-page":"234S","DOI":"10.1378\/chest.126.3_suppl.234S","article-title":"Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.","volume":"126","author":"Patrono","year":"2004","journal-title":"Chest"},{"key":"R66-24-20210210","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1158\/1055-9965.EPI-14-3-EDA","article-title":"What happened to the coxibs on the way to the cardiologist?","volume":"14","author":"Alberts","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R67-24-20210210","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/bmj.330.7504.1366","article-title":"Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.","volume":"330","author":"Hippisley-Cox","year":"2005","journal-title":"BMJ"},{"key":"R68-24-20210210","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.321.7270.1183","article-title":"Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis.","volume":"321","author":"Derry","year":"2000","journal-title":"BMJ"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2010349.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2010349","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2010349.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201012000-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:34:38Z","timestamp":1786541678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201012000-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":66,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2010.349","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}